Search company, investor...

Enzytech

Founded Year

1987

Stage

Acquired | Acquired

Total Raised

$21M

About Enzytech

Developer of two distinct product lines based on protein stabilization and manipulation technology. The Controlled Therapeutics Division is developing controlled or time-release polymers for use with pharmaceutical compounds. These polymers will reduce the need for multiple injections of specific drugs. The Food Ingredients Division is developing low fat, low calorie, natural food products. All technology is based on naturally occurring compounds rather than chemically-derived compounds. The Food Ingredients Division was spun-off in April 1991 as Opta Food Ingredients, Inc.

Headquarters Location

64 Sidney Street

Cambridge, Massachusetts, 02139,

United States

(617)252-0001

Missing: Enzytech's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Enzytech's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Enzytech Patents

Enzytech has filed 1 patent.

The 3 most popular patent topics include:

  • Psychiatric diagnosis
  • Abnormal psychology
  • Chemical processes
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/28/2018

4/16/2019

Psychiatric diagnosis, Metal halides, Chemical processes, Ketones, Phase transitions

Grant

Application Date

2/28/2018

Grant Date

4/16/2019

Title

Related Topics

Psychiatric diagnosis, Metal halides, Chemical processes, Ketones, Phase transitions

Status

Grant

Enzytech Frequently Asked Questions (FAQ)

  • When was Enzytech founded?

    Enzytech was founded in 1987.

  • Where is Enzytech's headquarters?

    Enzytech's headquarters is located at 64 Sidney Street, Cambridge.

  • What is Enzytech's latest funding round?

    Enzytech's latest funding round is Acquired.

  • How much did Enzytech raise?

    Enzytech raised a total of $21M.

  • Who are the investors of Enzytech?

    Investors of Enzytech include Alkermes, New Enterprise Associates, Bessemer Venture Partners, Venrock, Menlo Ventures and 6 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.